Heart Failure Clinical Trial
Sex and Obesity: Effects on Heart Failure Study
Summary
Sex has a major impact on myocardial metabolism and blood flow. In subjects without heart failure men's hearts tend to use proportionally more glucose and women's hearts use more fat and have higher blood flow.
Obesity is a major risk factor for Heart Failure. In subjects without heart failure, increasing body mass index is predictive of increased blood flow and fatty acid metabolism in women, but not men.
To measure blood flow and metabolism we will be using radioactive materials and a PET (positron emission Tomography)scan to study the metabolism of the heart.
Hypotheses: 1) Women with nonischemic heart failure will have higher levels of heart blood flow and fatty acid metabolism and lower glucose metabolism rates than men with nonischemic heart failure 2) Patients with obesity-related HF have a myocardial metabolic profile that is similar to that of obese subjects without heart failure and different (higher FA metabolism) from that of nonobese Heart failure patients.
Eligibility Criteria
Inclusion criteria
Heart failure (HF) and a systolic ejection fraction <45% per a recent echocardiogram report)
Nonischemic HF New York Heart Association Class II-III
Ambulatory
Able to give informed consent
On a stable medical regimen including the standard-of-care HF medications (i.e., a beta-blocker, ACE-inhibitor or angiotensin receptor blocker [ARB])
Exclusion criteria
Participants who were pregnant or lactating
Actively losing weight
Nonsedentary (performing aerobic exercise > 30 minutes x 3 times/week)
Those who have more than Class I hypertension
Those who require alterations in beta-blocker or ACE or ARB-inhibition medication
Those with hypertrophic, constrictive, or restrictive cardiomyopathies
Those unable to lie flat in the PET scanner
Severe major organ system dysfunction (other than heart failure)
Significant coronary artery disease by catheterization
Those unable to give informed consent
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Saint Louis Missouri, 63110, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.